Equity Profile

DVA

DaVita Inc.

Health CareHealth Care Services$15.1B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, focusing on dialysis and related healthcare services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a critical measure of profitability, and investors will be keen to see if DaVita can continue its trend of beating estimates.

$2.50

Revenue Growth

Revenue growth indicates the company's ability to expand its services and attract more patients, which is essential for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, focusing on dialysis and related healthcare services. As a key player in the health care sector, it plays a vital role in managing chronic kidney disease, which affects millions of people.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1 2026, DaVita reported an EPS of $2.87, surpassing expectations by 19%. The stock reacted positively, gaining nearly 2% the following day.

Management Promises & Guidance

Focus on expanding patient care services.
Commitment to improving operational efficiency.
Plans to enhance patient experience through technology.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about DaVita's upcoming earnings, especially after a strong performance last quarter. However, there are concerns about sustaining growth amidst increasing competition.

Bull Case

If DaVita can demonstrate strong EPS growth and an increase in patient count, it may signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet EPS expectations or shows signs of stagnation in patient growth, it could lead to a negative market reaction.

Key Metrics to Watch

EPS (Earnings Per Share)

$2.50

EPS is a critical measure of profitability, and investors will be keen to see if DaVita can continue its trend of beating estimates.

Revenue Growth

N/A

Revenue growth indicates the company's ability to expand its services and attract more patients, which is essential for long-term success.

Patient Count

N/A

The number of patients receiving treatment is a direct indicator of demand for DaVita's services and overall business health.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for Q2 2026?

EPS will be a key indicator of DaVita's profitability and ability to meet or exceed market expectations.

How many patients are currently receiving treatment?

The patient count will provide insight into the company's growth and demand for its services.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating DaVita's ability to expand its patient base, especially given recent trends in chronic kidney disease management.

Supporting Evidence

DaVita's recent EPS beat suggests operational strength that may not be fully reflected in current forecasts.

The options market indicates a significant expected move, suggesting traders are anticipating more than just a typical quarter.

Historical trends show that DaVita has consistently surprised to the upside, which could be overlooked by analysts.

Key Risk

If patient growth exceeds expectations, it could significantly alter the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on DaVita's ability to maintain profitability while expanding its patient base.

Bull Confirmed If

An EPS of $2.50 or higher would confirm the bull case and indicate strong profitability.

Bear Confirmed If

An EPS below $2.40 would support the bear case and raise concerns about the company's growth.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests the stock could rise by around 1.48%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further commentary from management.

Miss

A miss could lead to a decline of approximately 0.78%, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on patient growth and retention rates.
2Details on cost management and operational efficiency improvements.
3Insights into competitive pressures and market share.
4Comments on future growth strategies and service expansions.
5Management's outlook on the overall health care landscape.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

DaVita Inc. is a leading provider of kidney care services, focusing on dialysis and related healthcare services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a critical measure of profitability, and investors will be keen to see if DaVita can continue its trend of beating estimates.

$2.50

Revenue Growth

Revenue growth indicates the company's ability to expand its services and attract more patients, which is essential for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1 2026, DaVita reported an EPS of $2.87, surpassing expectations by 19%. The stock reacted positively, gaining nearly 2% the following day.

Management Promises & Guidance

Focus on expanding patient care services.
Commitment to improving operational efficiency.
Plans to enhance patient experience through technology.

Expectations

Wall Street Expectations

Bull Case

If DaVita can demonstrate strong EPS growth and an increase in patient count, it may signal robust demand for its services, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet EPS expectations or shows signs of stagnation in patient growth, it could lead to a negative market reaction.

Key Metrics to Watch

EPS (Earnings Per Share)

$2.50

EPS is a critical measure of profitability, and investors will be keen to see if DaVita can continue its trend of beating estimates.

Revenue Growth

N/A

Revenue growth indicates the company's ability to expand its services and attract more patients, which is essential for long-term success.

Patient Count

N/A

The number of patients receiving treatment is a direct indicator of demand for DaVita's services and overall business health.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for Q2 2026?

EPS will be a key indicator of DaVita's profitability and ability to meet or exceed market expectations.

How many patients are currently receiving treatment?

The patient count will provide insight into the company's growth and demand for its services.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating DaVita's ability to expand its patient base, especially given recent trends in chronic kidney disease management.

Supporting Evidence

DaVita's recent EPS beat suggests operational strength that may not be fully reflected in current forecasts.

The options market indicates a significant expected move, suggesting traders are anticipating more than just a typical quarter.

Historical trends show that DaVita has consistently surprised to the upside, which could be overlooked by analysts.

Key Risk

If patient growth exceeds expectations, it could significantly alter the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on DaVita's ability to maintain profitability while expanding its patient base.

Bull Confirmed If

An EPS of $2.50 or higher would confirm the bull case and indicate strong profitability.

Bear Confirmed If

An EPS below $2.40 would support the bear case and raise concerns about the company's growth.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests the stock could rise by around 1.48%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further commentary from management.

Miss

A miss could lead to a decline of approximately 0.78%, raising concerns about the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on patient growth and retention rates.
2Details on cost management and operational efficiency improvements.
3Insights into competitive pressures and market share.
4Comments on future growth strategies and service expansions.
5Management's outlook on the overall health care landscape.